To include your compound in the COVID-19 Resource Center, submit it here.

APTO-253: Phase Ib hold

FDA placed a clinical hold on an open-label, dose-escalation, U.S. Phase Ib trial of

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE